Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Traidl

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|November 18, 2021
[Allergen immunotherapy for atopic dermatitis]Stephan Traidl, Thomas Werfel
Dermatologie (Heidelberg, Germany)|June 1, 2022
[Modern systemic therapies for atopic dermatitis : Which factors determine the choice of therapy?]Stephan Traidl, Annice Heratizadeh
Journal of the European Academy of Dermatology and Venereology : JEADV|March 25, 2026
Paediatric psoriasis and biologics: An evidence gap in plain sightStephan Traidl, Sascha Gerdes
Immunotargets and Therapy|February 25, 2021
Anti-IgE for the Treatment of Chronic UrticariaBettina Wedi, Stephan Traidl
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|November 24, 2021
Stephan Traidl, Thomas Werfel
Allergologie Select|January 16, 2023
Prospective, monocentric, observational study of the long-term effectiveness of omalizumab in chronic urticariaStephan Traidl, Bettina Wedi
Clinical, Cosmetic and Investigational Dermatology|December 27, 2022
Real-World Experience with Tralokinumab in a Patient with Recalcitrant Atopic Dermatitis: A Case ReportEva Moennig, Stephan Traidl
Dermatologie (Heidelberg, Germany)|May 24, 2022
[Development of new topical substances for the treatment of atopic dermatitis]Sina Freimooser, Stephan Traidl, Thomas Werfel
Allergologie Select|September 17, 2021
Janus kinase inhibitors for the therapy of atopic dermatitisStephan Traidl, Sina Freimooser, Thomas Werfel
Dermatologie (Heidelberg, Germany)|August 4, 2022
Sina Freimooser, Stephan Traidl, Thomas Werfel
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|November 18, 2021
[Allergen immunotherapy for atopic dermatitis]Stephan Traidl, Thomas Werfel
Dermatologie (Heidelberg, Germany)|June 1, 2022
[Modern systemic therapies for atopic dermatitis : Which factors determine the choice of therapy?]Stephan Traidl, Annice Heratizadeh
Journal of the European Academy of Dermatology and Venereology : JEADV|March 25, 2026
Paediatric psoriasis and biologics: An evidence gap in plain sightStephan Traidl, Sascha Gerdes
Immunotargets and Therapy|February 25, 2021
Anti-IgE for the Treatment of Chronic UrticariaBettina Wedi, Stephan Traidl
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|November 24, 2021
Stephan Traidl, Thomas Werfel
Allergologie Select|January 16, 2023
Prospective, monocentric, observational study of the long-term effectiveness of omalizumab in chronic urticariaStephan Traidl, Bettina Wedi
Clinical, Cosmetic and Investigational Dermatology|December 27, 2022
Real-World Experience with Tralokinumab in a Patient with Recalcitrant Atopic Dermatitis: A Case ReportEva Moennig, Stephan Traidl
Dermatologie (Heidelberg, Germany)|May 24, 2022
[Development of new topical substances for the treatment of atopic dermatitis]Sina Freimooser, Stephan Traidl, Thomas Werfel
Allergologie Select|September 17, 2021
Janus kinase inhibitors for the therapy of atopic dermatitisStephan Traidl, Sina Freimooser, Thomas Werfel
Dermatologie (Heidelberg, Germany)|August 4, 2022
Sina Freimooser, Stephan Traidl, Thomas Werfel
Pageof 8